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Abstract
Thyroid hormone (T3) has a major influence on cerebellum post-natal development. The major phenotypic landmark of
exposure to low levels of T3 during development (hypothyroidism) in the cerebellum is the retarded inward migration of
the most numerous cell type, granular neurons. In order to identify the direct genetic regulation exerted by T3 on cerebellar
neurons and their precursors, we used microarray RNA hybridization to perform a time course analysis of T3 induced gene
expression in primary cultures of cerebellar neuronal cell. These experiments suggest that we identified a small set of genes
which are directly regulated, both in vivo and in vitro, during cerebellum post-natal development. These modest changes
suggest that T3 does not acts directly on granular neurons and mainly indirectly influences the cellular interactions taking
place during development.
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Introduction
3,5,39 tri-iodothyronine (T3), the active form of thyroid
hormone, acts by binding to its cognate receptors, thyroid
hormone receptors (TRs), which are transcription factors from
the nuclear receptor family [1]. TRs exist as three isoforms, TRa1,
TRb1 and TRb2, encoded by the Thra and Thrb genes
respectively. They can bind DNA both in the presence and
absence of T3, either as homodimers or as heterodimers with
RXR (Retinoid X Receptor). DNA binding occurs on so-called T3
response elements (TREs) which usually associate two consensus
half-sites (59AGGTCA39) often organized either as direct repeats
separated by four nucleotides (DR4). T3-liganded TRs have the
ability to induce either transcriptional activation or repression
depending on the locus and the local environment. For positive
regulation, unliganded TRs change conformation upon T3
binding, releasing transcription corepressors to recruit coactivators
and leaving epigenetic marks on neighboring histone tails [2].
Negative regulation mechanisms are poorly understood, and still a
matter of controversy.
The cerebellum is a very suitable structure to study T3 action
during neurodevelopment because it is particularly sensitive to
hypothyroidism [3]. Moreover, the cerebellum has a relatively
simple architecture compared to other brain regions, with only a
limited number of cell types. The cerebellar cortex is organized in
layers lying over the white matter and the deep cerebellar nuclei.
The cerebellar cortical layers comprise of the molecular layer
containing GABAergic interneurons, the Purkinje cell layer that
also contains the cell bodies of Bergmann glia cells and the internal
granular cell layer (IGL), containing mature granular cells,
astrocytes and Golgi GABAergic interneurons. During develop-
ment, granular cell precursors form a germinative layer over the
surface of the cerebellar primordium called the external granular
layer (EGL), where precursors divide actively and start their
differentiation after exiting the cell-cycle (for review see [4]). Post-
mitotic granular neurons extend their axon in the molecular layer
and migrate their cell body through the Purkinje cell layer to
populate the IGL. At post-developmental stages, granular neurons
represent more than ninety percent of cerebellar cells.
T3 deprivation during cerebellar post-natal development affects
all these cell types (reviewed in [5]). Granular cell migration is
blocked and granular cell precursors are trapped in the EGL after
the third post-natal week, when migration towards the IGL is
normally finished [6]. Purkinje cell layering is defective and the
size of their dendritic tree is reduced [7]. Bergmann glia fibers
morphology is abnormal, and astrocytes [8,9] show an over-
proliferation and delayed differentiation. Oligodendrocytes
[10,11] and GABAergic interneurons [12] differentiation is
delayed. Mouse genetics provided clear evidences that most if
not all of these defects are due to the presence of unliganded TRa1
in all cerebellar cell types. First, Thra knock-out reverses the
deleterious effect of hypothyroidism [13]. Second, dominant
negative mutations of TRa1, which affect either its ability to bind
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T3 or to recruit coactivators, lead to a cerebellar phenotype
resembling hypothyroidism [14,15,16]. Unlike Thra, Thrb is
expressed in only a few cell types and at low level in the
developing cerebellum. However, Thrb point mutation has also
been found to induce important cerebellar defects [17], raising the
possibility that T3 can initially act on few cell types, and indirectly
exert a global and indirect influence on a network of cellular
interactions.
Several attempts have been performed to elucidate the
molecular events underlying the observed cellular alterations in
hypothyroid cerebellum and identify the TRs target genes.
Various animal models have been used to identify genes which
expression levels are sensitive to T3 status [18–22] or which
promoters are directly bound by TR [23]. Although a number of
variations in mRNA levels were observed, most of these
experiments failed to establish a direct link between cells behavior
and TR regulated transcription, as changes in gene expression
might be explained by variations in neurotrophic factors levels,
which are secondary to T3 deficiency [21]. Cellular heterogeneity
of the cerebellum, which can mask variations in gene expression
restricted to one cell type, is also likely to impair the identification
of direct TR target genes in these experiments. Primary neuronal
cell cultures in part circumvent these problems as they allow
focusing on early events triggered by T3, limiting cellular
interactions and favoring neurons or glial cells by choosing
adequate culture conditions and thus reducing cellular heteroge-
neity. Up to now, and to our knowledge, RNA analysis of cultured
cells has demonstrated the direct upregulation by TRa1 (bound to
identified TREs) of only four genes, which are deregulated in
hypothyroid cerebellum: Hairless (Hr), synaptotagmin-related gene 1
(Srg1), [24] Krüppel-like factor 9 (Klf9) [25,26] and A kinase anchor
protein 1 (Akap1) [22]. To reach a better understanding of the
genetic regulation underlying the neuronal defects observed in
hypothyroid brain, we performed a genome-wide transcriptome
analysis of T3 response in primary cerebellar neurons culture. This
identified 15 genes, which are either up- or down-regulated by
TRa1 in response to T3. We further studied whether these genes
are directly regulated by TRa1 in vitro and in vivo in different cell
types of the cerebellum and in a cerebellum cell line. We chose to
work on the C17.2 cell line [27] since it is derived from EGL cells
and thus was supposed to be closely related to our primary
cultures. We used this cell line to have a more convenient access to
chromatin binding since it is easier to realize chromatin
precipitation in cells rather than in tissues, particularly in our
case where there is no ‘‘ChIP grade’’ antibody for TRa1.
Results
Genome-wide Search of T3 Regulated Genes
In order to identify changes in gene expression which are
mainly related to immediate and direct action of thyroid hormone
on post-natal cerebellum neuronal cells, we prepared primary
cultures of cerebellar cells and maintained them in conditions
favoring neurons survival, at the expense of glial cell proliferation.
It has been shown that in this system, granular neurons, which
represent the majority of cerebellar cells, switch from proliferation
to migration and finally terminal differentiation, including
dendritogenesis [28], thus reproducing the normal stages of
development. We verified by immunocytochemistry that in these
conditions most of the cells (80%) express the Tuj1 neuronal
markers, and that prolonged culture (10 days) allowed the cells to
grow fine dendritic-like processes. Two days after seeding, cells
were treated with T3 for various amounts of time (6, 16, 24 or 48
hours) or left untreated before RNA extraction. Total RNAs were
then amplified and cDNA prepared to serve as probes for
microarrays hybridization. (See dataset GSE24793 on the NCBI
Gene Expression Omnibus (GEO), http://www.ncbi.nlm.nih.
gov/geo/).
Only probe-sets with a sufficient level of expression (P in
columns ‘‘detection’’ of data matrix available at the GEO
depository, covering about 40% of all annotated genes) and that
showed a fold change superior to 2 were considered. We detected
signals for markers for each cerebellar cell-type, indicating that our
culture system contained all the cell constituents of the cerebellum
and we also found that its composition evolved over time. For
example, at early time points we detected high levels of Pax6 and
Ccnd2, two markers of granule cell precursors, which decreased
over time. Conversely, we observed low levels of Gabra6, a marker
of differentiated granule cells, which increased over time. We also
detected Pcp2 expression, a marker of Purkinje cells, Pdgfra and
Plp1, markers of oligodendrocyte precursors and of mature
oligodendrocytes, respectively, and Slc1a3 (Glast) and Gfap, two
markers of Bergmann glia and astrocytes.
To address the robustness of T3 regulation in primary cultures
of cerebellar cells, we used Q-RT-PCR to compare the microarray
results acquired with a first set of primary cultures to RNA
expression of both the same and another independent primary
cultures experiment. We generated primers for the most up- or
down-regulated genes for each time point and for genes showing
an overall constant tendency (up- or down-regulated for all time
points) from the microarray results. Given the relatively low
numbers of probe-sets corresponding to these criteria, we also
selected genes showing a change in expression of at least 1.6 fold
for one or more time points, and genes that were previously known
to be regulated by T3, like Ccnd2 or Hr. We confirmed that T3
induced changes in gene expression for a number of genes and the
changes in expression pattern increased over time. 6 genes were
up-regulated and 9 were down-regulated in a significant and
reproducible manner (Table 1). We focused later investigations on
this group of 15 putative TR target genes The group of up-
regulated genes included the previously reported T3 target gene
Klf9. Hr expression was too low to be detected by microarray
hybridization, but its expected induction by T3 was confirmed by
Q-RT-PCR. This result is consistent with Q-RT-PCR being a
more sensitive detection method of RNA than microarray
hybridization, and indicates that our survey, although revealing
expression of about 40% of the annotated genes in the cultured
cells, might have missed some changes in gene expression, due to
limited sensitivity. However, detection of mRNA expressed by
very limited cell populations (see above, ie, Pcp2 in Purkinje cells)
suggests that it was not the case.
In vitro Study of Target Genes Regulation of Expression
The fact that most of the genes that we identified were distinct
from those that have been identified in previous studies
prompted us to address the possibility that some genes might
be regulated in specific cell types, or at specific differentiation
steps, whereas others would be regulated more broadly. To study
the expression of the T3 regulated genes on another cellular
background we used C17.2 cerebellum immortalized pluripotent
cell line, which originates from EGL [27]. Although the exact
nature of these cells is unclear [29], they are able to differentiate
into granular-like neurons when grafted in brain [30]. We first
restored C17.2 cells response to T3 by expressing a tagged
version of TRa1 in a stable manner and measured the expression
of Hr in response to TR and T3 (Fig. 1A). We found that both
C17.2 and C17.2/TRa1 cells can differentiate within 5 days to
Tuj1+ neuronal-like cells in serum-free Neurobasal medium.
Few TRa Targets in Cerebellar Neurons
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Interestingly, in this differentiation assay, the presence of T3
completely prevented the appearance of Tuj1+ cells in C17.2/
TRa1 but not in C17.2 (data not shown). We then addressed the
expression of the 15 novel TR target genes, identified in primary
neuronal cultures, in C17.2/TRa1 cells after 48 hours of T3
stimulation in the presence or absence of serum. Figure 1b
indicates that, soon after serum deprivation, T3 regulation was
visible in these cells, with 3 exceptions (Plxna2, Spata13 and Vnn1).
Interestingly, the T3-induced changes in gene expression in
presence of serum were mainly limited to Hr induction. Although
thought to be expressed only in the oligodendrocytes lineage,
Plp1 was activated in serum starved C17.2/TRa1 cells, which
did not express other typical oligodendrocyte markers, like Mbp
gene, encoding the Myelin Basic Protein (data not shown).
The C17.2/TRa1 cell line appears therefore as a convenient in
vitro model to study the T3/TRa1 signaling pathway in a neural
context. It offers the possibility to assess if TRa1 is bound to
consensus binding sequences (TR response element, TRE) at
proximity of the target genes transcription start site (TSS). Using
previous bioinformatics data [22], putative TREs conserved
between mouse and human were first identified within 25 kb of
transcription start sites (TSS). When no conserved sequence was
found, Nubiscan online tool (http://www.nubiscan.unibas.ch/)
was also used to extend the search to near-consensus sequences in
this region. This gave us a list of putative TREs for each locus
(Table 2). Taking advantage of the proteinG tag present on TRa1,
we performed Chromatin Affinity Purification (ChAP) to enrich
fractionated chromatin into TRa1 bound complexes. This
confirmed the presence of TRa1 in areas covering some of
previously reported TREs, upstream to Klf9 [26], Hr [22] and Dbp
[23], and one downstream to the transcription start site of Gbp3
(Table 2). The transcriptional regulation for these genes is thus
likely to result directly from the activation of TRa1 bound to
neighboring regulatory sequences. We also used a recombination
mediated cassette exchange assay [31] to address the ability of
upstream promoter sequences of these genes to drive the stable
expression of renilla luciferase in C17.2/TRa1 cells and mediate T3
regulation in a physiological chromatin context. This confirmed
the presence of T3 regulatory elements within 6 kb of upstream
sequences for Hr but not for Gbp3 and Anxa8 (data not shown).
In vivo T3 Target Genes Expression and Regulation by
TRa1
As Thra is expressed in all cerebellum cell types, we used
transgenic mice which express a dominant negative mutation of
the TRa1 receptor (TRa1L400R) to address the in vivo relevance of
the gene regulation observed in cultured cells. TRa1L400R can be
expressed from the so called TRaAMI allele of Thra only when a
transcription stop cassette is deleted by CRE/loxP recombination.
In TRaAMI/S mice, excision takes place soon after fertilization,
and TRa1L400R expression is nearly ubiquitous. TRaAMI/S mice
display the defects in EGL migration and Purkinje cells
arborization, which define congenital hypothyroidism in post-
natal cerebellum [14,16]. Q-RT-PCR of cerebellum RNA showed
that significant alterations of gene expression between wild-type
and TRaAMI/S mice at various developmental stages for the
identified genes, indicating that these genes can be regulated by
liganded TRa1 during cerebellum development, at least at one
developmental stage (Figure 2). These results confirmed the
predominant in vivo function of TRa1 and the relevance of the cell
culture systems that we used. Expression kinetics revealed a variety
of expression patterns, corresponding to the dynamic changes that
occur during cerebellar development, and suggested that, for each
gene, T3 sensitivity is restricted to a temporal window, sometimes
limited to one time point. For some genes, opposite effects on
expression of a target gene in wild-type and TRaAMI/S were
observed at different time points, suggesting that a combination of
different T3-mediated regulation mechanisms takes place during
development. These variations in mRNA levels can however be
influenced by modifications in cellular composition of the
cerebellum due to the adverse developmental effects of TRa1L400R
and subsequent bias in whole cerebellum mRNA content.
To address this last possibility, we examined expression patterns
for the identified target genes, using adult and fetal gene
expression databases (Allen Mouse Brain Atlas, http://mouse.
brain-map.org/welcome.do and Gensat, http://www.ncbi.nlm.
nih.gov/projects/gensat/) and cell-type specific transcriptome
Table 1. Q-RT-PCR confirmation of T3 mediated regulation in primary cultures of cerebellum neuronal cells.
Gene Full name Microarrays Q-RT-PCR
6h 16h 24h 48h 6h 16h 24h
Anxa8 Annexin 8 1,16 0,62 1,41 0,54 0,92 1,12 0,67
Dbp D-site albumin promoter binding protein 2,65 3,06 2,47 1,87 2,14 1,87 1,75
Gbp3 Guanylate binding protein 3 1,41 1,62 3,48 1,74 1,30 1,85 2,50
Igsf3 Immunoglobulin superfamily, member 3 0,80 0,80 0,36 0,90 1,01 0,98 0,76
Klf9 Krüppel-like factor 9 2,49 1,92 3,09 1,76 5,48 9,21 4,04
Pfkfb3 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 2,00 1,32 1,30 1,27 1,36 1,93 1,62
Plp1 Proteolipid protein 1 1,55 1,33 0,37 2,19 1,13 1,09 0,92
Plxna2 Plexin A2 1,94 0,67 1,09 1,29 0,97 1,04 0,97
Snap25 Synaptosomal-associated protein, 25 kD 1,15 1,19 1,08 1,76 1,98 2,06 2,92
Spata13 Spermatogenesis associated 13 2,05 1,63 2,06 1,39 2,62 2,00 2,58
Tgm2 Transglutaminase 2 0,93 1,05 1,48 0,64 1,09 1,17 0,90
Vnn1 Vanin 1 0,93 0,52 1,46 0,62 1,13 0,94 N/A
Zbtb20 Zinc finger and BTB domain containing 20 1,21 1,21 1,25 1,37 1,58 1,26 2,82
Bold characters outline fold changes superior to 2.
doi:10.1371/journal.pone.0030703.t001
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analysis based on tagged ribosomes immunoprecipitation [32]
(Table 3). Preferential Anxa8, Plxna2 and Spata13 expression seems
to occur in granular cells and in their EGL precursors. Therefore,
the observed increase in Anxa8, Plxna2 and Spata13 mRNA at P21
might at least in part reflect the persistence of EGL in TRaAMI/S
cerebellum at late stage, rather than a transcriptional regulation.
Although granular neurons and their precursors represent the
majority of cells present in cerebellum and in the primary cell
cultures that we initially used, it is striking that the number of
genes found to be expressed preferentially in this lineage is very
limited (Anxa8, Hr, Plxna2). By contrast, we picked up specific
expression of glial cells (Plp1) and GABAergic neurons (Dbp, Pfkfb3,
Tgm2), although these cell types were clearly under-represented in
the primary cells culture system that we initially used.
Cell Autonomous and Indirect Regulations
As TRa1L400R expression in transgenic mice depends on the
Cre/loxP recombination system, we can address whether the in
vivo regulation by TRa1 on T3 sensitive gene is a cell
autonomous process, a feature that is an important indicator of
a direct transcriptional control, by expressing TRa1L400R in
defined cell types. We crossed TRaAMI mice with transgenic mice
expressing the CRE recombinase in restricted cell populations.
The TRaAMI/O mice expresses a tamoxifen inducible version of
the recombinase in the granular neurons of the posterior lobules
of the post-natal cerebellum (Otx2CreERT2, [44]) and we
therefore expected an inhibition of TRa1 function in the
granular cell lineage in this model. TRaAMI/P mice express
TRa1L400R during fetal life in Purkinje cells and GABAergic
interneurons progenitors (Ptf1a-Cre, [45]). TRaAMI/C mice
express the mutation in the oligodendrocytes and their commit-
ted precursors (Cnp-Cre [46]). Tamoxifen treatment of TRaAMI/
O at P1 followed by Q-RT-PCR analysis at P8 revealed a change
in gene expression only for Cdh1 and Klf9 (Table 4), in keeping
with the putative expression patterns established previously.
TRaAMI/C mice displayed deregulation of Igsf3, a possible
indication of regulation in the oligodendrocytes lineage. Howev-
er, most changes in gene expression were observed in TRaAMI/P
mice, where TRa1L400R expression was restricted to GABAergic
neurons. Cdh1, Dbp, Pfkfb3 and Tgm2 are thus possibly regulated
by TRa1 in neuronal cell types that were under-represented in
the initial culture conditions. Interestingly, some of the changes
in gene expression found in TRaAMI/P mice are clearly not cell
autonomous consequences of TR1L400R expression in GABAer-
gic neurons, but affect expression either in oligodendrocytes
(Plp1) or granular neurons (Plxna2). This might reflect an indirect
response of this last cell type to diffusible factors secreted by
GABAergic neurons under T3 stimulation.
Discussion
By using a cell culture system aimed at maximizing T3 response
of cerebellum cells, we were able to identify new T3 target genes,
which are either up- or down-regulated during normal cerebellum
development. Among the genes identified by our screen, only four
were already reported as being regulated by T3, sometimes in
other brain areas and at different stages: Hr [47], Snap25 [48], Dbp
[49] and Klf9 [50]. Among the identified genes, some are regulated
Figure 1. Transfection of TRa1 into C17.2 cells restores their response to T3 treatment. A. T3-induced Hr expression is detected earlier and
stronger in transfected C17.2/TRa1 cells (black bars) than in non-transfected cells (white bars), *p,0.05, Student’s t-test difference between non-
transfected cells and C17.2/TRa1 cells. B. The level of change in expression induced by T3 and measured by Q-RT-PCR in C17.2/TRa1 cells is indicated
for each target gene, using non-treated cultures as reference (represented as log2 of the fold change). White bars indicate T3 treatment in
proliferative medium (containing serum), black bars indicated T3 treatment in serum-deprived medium allowing for differentiation. Most genes show
a response only in serum-deprived medium, *p,0.05, Student’s t-test, difference between serum containing and serum deprived cultures.
doi:10.1371/journal.pone.0030703.g001
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Table 2. Chromatin occupancy by TRa1 in C17.2/TRa1 cells.
Gene Conserved TRE position Type TRE Sequence TRa1 affinity precipitation (enrichment)
Anxa8 213935 DR4 GTGTCAtgcaAGGTCA 0.7460.13
28825 DR4 GGGGCAtccgAGTTCA 0.6960.12
27406 DR4 AGGTCActccAGGTCC ND
2314 DR4 AGTTCAgcaaAGGACA 0.6660.19
Cdh1 29477 DR4 AGTTTAtgtaAGGTCA ND
22600 DR4 GGGACAgaaaGGGTCA 0.8860.03
+1784 DR4 AGGTCAttttGGTGCA 1.4860.34
+14093 DR4 GGGTCAccaaGTGTCA 1.1560.22
+19817 DR4 AGGTCAcgggAGTTAA 1.1260.23
+22206 DR4 AGTTCAagtgAAGTCA 0.9860.07
+8445 ER6 TGTCCTcagggaAGTTCA 1.1560.17
Dbp 217879 DR4 TGGTCAtagcAGGTCA 1.2360.10
210039 DR4 GGGTTAaggaAGTTCA 1.0360.08
+18318 DR4 AGGTCActggGGTTCC 1.1460.15
2341 DR4/ER6 TTGGCCAAatatAGGTCA 2.57±0.04
Gbp3 +406 DR4/ER6 TCAGCTCAgctgAGGTCA* 5.5±0.14
+10643 IR0 AGGTCATGACCT* 1.260.23
Hr 22345 DR4 AGGGCAtctgAGGACA* 9.5±1.12
Igsf3 +8259 DR4 AAGTCAactgAGGTCA 1.7760.22
+9904 DR4 GGGTGAcagaAGGTCA 0.7360.13
+12575 DR4 ATGTCAagagAGTTCA ND
+18783 DR4 AGGACAcacgAGGTCA 2.08±0.09
Klf9 25206 DR4 GGTTCAtttgAGGACA 7.13±1.04
23763 DR4 AGGTGAagtgAGGTCA 6±0.67
219085 IR0 CGGTCATGACCC 0.6660.10
Pfkfb3 223043 DR4 AGGCCAccctAGGTCA ND
221724 DR4 AGTACAcaggAGTTCA ND
213326 DR4 AGGTCAggagAATTCA ND
21305 DR4 AGGCCAgccaGGGTCA ND
+519 DR4 AGGTCAaggtAGGTCT ND
+15186 DR4 GGTTAAggcaGGGTCA ND
Tgm2 210668 DR4 AGGTCAgcaaAAGTCA 0.8260.16
+5402 DR4 GGGTCTaaagGGGTCA ND
213773 IR0 AGGTCATGACCT ND
Plp1 222862 DR4 GGTGCAgctgGGTTCA ND
2722 ER6 TGACCTtggcacAGGTCT ND
+5330 DR4 AGGGCAtttaAGTTCA ND
Plxna2 +10679 ER6 TGACCAaaccttAGTTCA ND
Snap25 Not found N/A N/A N/A
Spata13 213751 IR0 AGGTCAAGACCT* ND
Vnn1 21676 DR4 AGTTAAgaggAGGTCA ND
+23666 DR4 GGGCCAaataAGTTCA ND
+21041 DR4 AGGTCAgggtGGGTCA ND
Zbtb20 217282 DR4 GGTTCTtacaAGTTCA ND
211201 DR4 GGTTCAcagaGGGCCA ND
210524 IR0 AGTTGATGACCT ND
*Identified using NUBISCAN. Bold characters correspond to TREs with more that 2-fold enrichment after C17.2/TRa1 cells ChAP. ND: not determined, N/A: not relevant.
Mean 6 SD for three independent experiments.
doi:10.1371/journal.pone.0030703.t002
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during early development, possess TREs in their regulatory
sequences, which can be actually occupied by TRs, and are
sensitive to the expression of a dominant negative TRa1 mutation
in a cell-autonomous manner. These genes (Hr, Dbp, Klf9, Gbp3)
are, beyond any reasonable doubt, direct TR targets. For the
others the demonstration is only partial and alternative explana-
tions for changes in genes expression are possible. In some cases
(Plp1, Plxna2, Tgm2), slow kinetics could be an indication that they
are secondary targets, activated by transcription factors which
expression is itself regulated by T3, or by some of the neurotrophic
signaling pathways that are activated by T3. Nevertheless, this
study provides with a list of genes that may be important for
cerebellar development and which role in this process would be
worth investigating.
This study is at least the fourth attempt to identify T3 target
genes in the cerebellum by broad transcriptional analysis, and
there is little overlap between datasets. Although the discrepancies
between the present and previous studies might in part be due to
technical reasons, we believe that most differences can be
explained by the fact that the repertoire of TRs target genes is
highly dependent on cell types and, as indicated by our in vivo data,
developmental stage. Here we favored the discovery of genes
regulated by T3 in neurons, especially in the most abundant
granular neurons, whereas previous attempts focused on whole
cerebellum at early [18] or late [20–22] time points. Interestingly,
only two of these genes (Hr, Klf9) have been identified as T3 target
genes in neurons from several brain areas and at different stages in
mice and even in frogs [22,26,50,51,52] and seem to possess the
singular property to be inducible by T3 in various cellular
contexts.
Current knowledge provides few indications that the gene
regulations that we observed might significantly impact cerebellar
development. However, Klf9 knock-out mice show a deficit in the
rotarod test, a sign of cerebellar disorder [36]. Its function in
granular neurons remains unknown. Zbtb20 encodes a transcrip-
tion factor able to specify neuronal identity [53,54]. Plp1 is a gene
encoding one of the major myelin component, proteolipid protein,
expressed in oligodendrocytes. Thyroid hormone is known to be
essential for oligodendrocytes differentiation [10] and thus for Plp1
expression [55]. According to our data, Plp1 is however unlikely to
be a direct T3 target gene, and its in vivo down-regulation might
just reflect a delay in oligodendrocytes differentiation. The fact
that we detect changes in its expression in microarrays might be
due to a less oligodendrocyte-restricted expression that previously
known [56]. According to our observation Plxna2 gene is also
sensitive to T3 signaling in vivo, but its deregulation by expressing
the mutant TRa1 only in GABAergic neurons although this gene
is expressed in granular cells suggest that Plxna2 is not a direct
TRa1 target gene. It encodes a semaphorin receptor family
member, which, by binding to its ligand, SEMA6A, promotes
granule cells migration [39]. For both Plp1 and Plxna2, some
unknown primary event is triggered by T3, possibly in Purkinje
neurons, as indicated by the TRaAMI/CRE models. Purkinje
neurons cells secrete a number of neurotrophic and growth factors
that coordinate cerebellum development [57]. The majority of the
other newly identified TR target genes encode proteins with
known functions, relevant to synaptic transmission (SNAP25),
transcription factors (Zbtb20, DBP), adhesion and extracellular
matrix proteins (ANXA8, CDH1, TGM2), signal transduction
(Spata13) and cell survival (Tgm2). However, mouse genetics have
not yet established their involvement in cerebellum post-natal
development. The metabolic function of the Pfkfb3 gene product,
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3, is well
known. This enzyme regulates the steady-state concentration of
fructose-2,6-bisphosphate, a potent activator of a key regulatory
enzyme of glycolysis, phosphofructokinase. Glycolysis is sensitive
Figure 2. Kinetics of T3 target genes expression in wild-type and TRaAMI/S mice in the cerebellum as measured by Q-RT-PCR.
Expression levels were calculated for each target gene by Q-RT-PCR in wild-type and TRaAMI/S littermates at P4, P8, P15 and P21 (minimum 3 animals
of each genotype for each time point). Data are expressed as mean 6 SD using wild-type P4 values (A), for genes with decreasing or stable expression
levels over time or P21 (B), for genes with increasing expression levels, as a reference for each genotype. *p,0.05; **p,0.01 for comparisons between
wild-type and TRaAMI/S mice for each time point (Student’s t-test).
doi:10.1371/journal.pone.0030703.g002
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to T3 in several cell types, and a key parameter for neuronal
activity. Glucose consumption was found to be reduced in the
brain of mice expressing a TRa1 dominant-negative mutation
[58]. Overexpression of Pfkfb3 is however detrimental to neurons
[59] as it favors the accumulation of toxic free radicals, a possible
consequence of T3 excess in several systems [60]. This provides a
possible explanation for increased neuronal cell death in hyper-
thyroid post-natal cerebellum [18]. As we found little glucose
consumption in our primary cultures (data not shown), pyruvate
being probably used as a substitute for energetic metabolism, we
cannot address the metabolic consequence of Pfkfb3 stimulation in
our in vitro system.
Our initial broad survey identified a small number of genes in
T3 sensitive genes in granular neurons, whereas it revealed T3
response of genes expressed in Purkinje neurons, and even in
oligodendrocytes. This is a striking observation, considering that
this two last cell types were a small minority of the cultured cell
population and that EGL persistence at P21 and granular cells
defects in differentiation and migration are the major landmarks of
hypothyroidism. The fact that transcriptome analysis was sensitive
enough to detect variations of rare mRNA prompts us to suggest
that the total number of T3 target genes in granular neurons is
very small, although it includes two of the best characterized
examples: Hr and Klf9. That few genes are regulated by T3 in the
granular cell precursors which populate the EGL is consistent with
recent results showing that Thra expression is weak in the
proliferating granular cells precursors [61,62]. However, this
explanation does not hold for post-mitotic granular neurons, but
granular cells were mainly in precursor state when we did our
primary cultures (P1–P4). The broad survey that we performed
convinces us that most of the T3 direct response does not occur in
the granular lineage that represents the vast majority of the
cerebellum cell population at this stage, although thyroid hormone
could have a major role on granular cell terminal differentiation at
later stages. At early stages, our data suggests that T3-mediated
gene regulation is mainly taking place in few cell types, including
Purkinje cells, that play a pivotal role in a network of cellular
interactions, mediated by direct contacts and neurotrophic factors
secretion. The small number of target genes suggests that the
cellular alterations observed in hypothyroid cerebellum are mainly
indirect consequences of minor initial imbalance in gene
expression, and that T3 controls the expression of few key
developmental genes in cerebellum neurons. If our interpretation
is correct, congenital hypothyroidism in cerebellum might be
viewed mainly as desynchronization of the cellular interactions
which govern proper neurodevelopment.
Materials and Methods
Animals
All animals used in this study were housed, raised, bred and
used in accordance with European directive 86/609/EEC and in
compliance with national and international rules and laws on
animal welfare. Heterozygous mice expressing the TRa1L400R
ubiquitously were produced by using the sycp1CRE transgene
expressed in spermatogonia [14]. Cell specific recombinations
were obtained by crossing TRaAMI mice with OtxCRE-ERT2
[44], Ptf1aCRE [45], CnpCRE [46]. Recombination patterns
were verified by PCR [14] and by crossing with reporter
transgenic ROSAYFP mice and immunocytochemistry [63].
Primary Cultures of Newborn Mice Cerebellar Neurons
Newborn mice (P1–P4) were decapitated and the cerebellum
was rapidly recovered in a Petri dish containing HBSS medium
without Ca2+or Mg2+supplemented with 1 mM pyruvate and
10 mM Hepes. Cerebella were pooled and then washed and
dissociated in 1 mL of the same medium. 2 mL of HBSS (with
Ca2+and Mg2+)/1 mM pyruvate/10 mM Hepes was added and
Table 4. Cell autonomous effect of in vivo expression of a dominant negative TRa1 mutation.
Genes
TRaAMI/S
P15
TRaAMI/C
P15
TRaAMI/P
P15
TRaAMI/S
P8
TRaAMI/O
P8
TRaAMI/P
P8
N = (WT/mutants) 7/4 3/5 5/3 4/3 3/3 4/5
Anxa8 2.0460.90 0.9060.22 1.1560.47 0.5860.26 1.0460.90 0.59±0.25*
Cdh1 0.48±0.11** 1.2660.53 0.45±0.11* 1.7660.39 0.68±0.13* 1.0360.63
Dbp 0.7560.04 ND 0.71±0.13** 0.8860.17 0.8760.09 1.3060.29
Gbp3 0.71±0.11* ND 0.6460.06 0.5060.16 0.6560.24 0.6760.39
Hr 0.22±0.13** 0.7060.36 0.80±0.16* 0.61±0.07* 0.8160.26 1.8260.61
Igsf3 3.34±1.87* 7.55±2.12** 0.8860.15 0.9360.08 1.0260.08 0.5760.28
Klf9 0.47±0.17** 0.9160.50 1.2360.49 0.7460.16 0.67±0.08* 1.0660.43
Pfkfb3 1.3760.321 ND 0.75±0.19* 0.9560.17 0.8060.12 0.20±0.11**
Plp1 0.60±0.10** 1.8060.61 0.8060.17 1.0360.32 0.5260.15 0.41±0.16**
Plxna2 2.56±0.42** 1.2060.61 0.8460.17 0.8660.11 0.7460.19 0.51±0.22*
Snap25 0.43±0.13** ND 0.9460.22 0.7660.07 0.7360.07 0.9460.58
Spata13 2.39±0.15** ND 0.9960.25 0.9060.17 0.7360.32 1.5260.341
Tgm2 1.76±0.28** 0.8460.23 0.9560.28 0.9660.03 0.9260.05 0.43±0.11*
Vnn1 3.6461.42 ND 0.9160.10 0.7560.20 1.1660.05 1.1660.66
Zbtb20 2.1060.89 ND 0.9760.09 0.5960.21 0.7560.42 1.1960.23
TRaAMI/S data are reported from figure 2 for comparisons. ND: Not determined. Values are indicated as mean 6 SD. Significant changes (Student T-test) are indicated in
bold:
**: p,0.01,
*: p,0.05.
doi:10.1371/journal.pone.0030703.t004
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cells were centrifuged 1 min at 200 g. Supernatant was removed,
cells were resuspended in Neurobasal medium containing 2% B27
supplement, 0.5 mM L-glutamine and 0.5% penicillin-streptomy-
cin and plated in 24-wells plates coated with poly-lysine (0.05 mg/
mL). All cell-culture media were purchased form Gibco-Invitrogen.
Cultures were maintained for 48 hours after seeding to favor
neuronal survival at the expanse of glial cells and then treated with
0.1 mM T3 for 6, 16, 24 and 48 hours (one culture for each time
point). Control cultures were submitted to the same scheme of
medium change without addition of T3. Batches of cells were
allowed to grow for up to 10 days and screened for expression of
neuronal or glial markers by immunohistochemistry. This set of
cultures and another set of primary cultures comprising the same
conditions have been used for confirmation by Q-RT-PCR.
RNA Extraction
Total RNA was extracted from cell cultures or mice cerebella
with the Qiagen RNeasy kit according to manufacturers recom-
mendations. RNA qualities and quantities were verified by
capillary electrophoresis (BioAnalyser, Applied Biosystems) before
reverse-transcription.
Microarrays Hybridization
1 mg of each RNA was reverse transcribed and cDNA were
submitted to one round of linear amplification before hybridiza-
tion to whole-genome mice Affymetrix microarrays (GeneChip
Mouse Genome 430 2.0 Array). One microarray was used for each
condition. Data were analyzed using the Affymetrix GCOS
software, data were normalized by Affymetrix MAS5.0 software,
providing an estimation of expression levels for each probe-set and
a p-value of the significance of the expression change. Data were
pairwise compared for each time point between a T3-treated
culture and a matched untreated culture prepared simultaneously
from the same cell batch. This work was done by the Bio-
informatics and Expression Analysis core facility at Karolinska
Institutet (Sweden).
Quantitative Reverse Transcription-PCR (Q-RT-PCR)
For Q-RT-PCR on mouse cerebella, 1 mg of each RNA sample
was reverse-transcribed using MLV reverse-transcriptase (Pro-
mega). Quantitative PCR were then performed in 96 wells-plates
using the hypoxanthine guanine phosphoribosyl transferase gene as a
reference after carefully checking that our conditions did not
significantly modify its expression level (less than one Ct of
difference between compared samples, see also [22]) and the
following mix: 4 mL of primers (see primers list in Table S1) mix
1.2 mM, 6 mL of SYBRGreen mix (either Qiagen Quanti-tect mix
or Biorad iQ supermix) and 2 mL of cDNA diluted 1 in 20. A
standard curve was made for each gene and each measure was
made in triplicates. Melting curves were analyzed to ascertain
homogeneity of the amplified products. Expression levels were
calculated using the 22DD(Ct)method [64]. Statistical differences
have been calculated using unpaired Stutent t-test assuming
different group sizes and variances.
C17.2 Culture and C17.2/TRa1 Cells
C17.2 neural cells [18] were grown in DMEM medium (4.5 g/
L glucose, glutamine, pyruvate) containing 10% FBS, 5% horse
serum, 1% glutamine, 1% penicillin-streptomycin. Cells prolifer-
ate in this medium and were split 1/10 each week. Sera used for
cell culture were deprived of T3 either by activated charcoal or
resin treatment. When cultured without serum, serum removal
was done simultaneously with T3 treatment. For testing target
gene expression after transfection and in medium with or without
serum, three independent experiments have been done.
pCEMM-GS-TRa1 was constructed by inserting the murine
TRa1 reading frame amplified by PCR into the BamHI site of
pCEMM-NTAP [65] create a reading frame encoding a GS-
TRa1 protein, tagged at its N-terminus by a fragment of protein
G. A downstream IRES-gfp cassette located on the transcription
unit ensured co-expression of a green fluorescent protein.
pCEMM-GS-TRa1 was co-transfected into C17.2 cells with
pPGK-Puro and puromycine resistant cells were submitted to two
rounds of sorting to select cells with stable expression of both gfp
and GS-TRa1. This was further confirmed by Western blotting
using an anti-TR antibody (Santa Cruz).
Chromatin Affinity Purification (ChAP)
This method differs form chromatin immune-precipitation
(ChIP) in that it does not involve an antibody directed against
the DNA-binding protein of interest but relies on affinity binding
between the tagged protein and other molecules bound to beads
(in our case the protein G tag and IgG beads, see [65]). T3-treated
or non-treated C17.2 cells were rinsed with PBS and cross-linked
with 1% paraformaldehyde in PBS for 10 minutes at 37uC. Cells
were then harvested, and stored at 280uC as pellets. Cell pellets
were resuspended in 300 mL lysis buffer (1% SDS, 10 mM EDTA,
50 mM Tris pH 8) and sonicated 8 min (30s ON/30s OFF, high
intensity) with a bath sonicator (Bioruptor, Diagenode). A small
aliquot of cell lysate was analysed by gel electrophoresis and size of
DNA fragments verified to be between 200 and 800 bp. 100 mL of
the cell lysate was kept as input and the rest was diluted 1 in 10 in
dilution buffer (1% Triton X-100, 1 mM EDTA, 150 mM Na Cl,
20 mM Tris pH 8) and incubated with IgG-coated magnetic
beads (Invitrogen) at 4uC overnight. Negative control was
obtained with non-transfected C17.2 cells. Beads were then rinsed
twice in TSE1 buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 150 mM NaCl, 20 mM Tris pH 8), three times in TSE2
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 500 mM
NaCl, 20 mM Tris pH8), twice in LiCl wash buffer (0.25 M LiCl,
1% NP-40, 1% Sodium deoxycholate, 1mM EDTA, 1 mM Tris
pH 8), twice with TE (10 mM Tris-HCl, 1 mM EDTA pH 8) and
DNA fragments were eluted in 0.1 M NaHCO3, 1% SDS. Cross-
link was reversed by overnight incubation at 65uC in 200 mM
NaCl. DNA was purified using the Qiagen minElute kit, and
quantified by Q-PCR as described above. Calibration curves were
made with dilutions of input DNA and purification rates were
calculated using the 22DD (Ct) method as input percentages. For
each gene, a distal promoter DNA sequence was used as a control
for non-specific background binding (see Table S2 for position of
amplified sequence for both putative TREs and negative control).
Enrichment was calculated as the ratio between input percentages
of specifically bound quantity and non-specific binding. Prelimi-
nary experiments, using non-transfected cells, allow to set a
threshold of 2-fold enrichment, as a minimum to ascertain genuine
receptor binding (see Table S2 for primer sequences). Non-
transfected cells gave no enrichment and no increase in
purification in the precipitated fraction for any putative TRE
(data not shown). Each putative has been tested on three
independent ChAP experiments and results were well reproduc-
ible when enrichment was observed.
Supporting Information
Table S1 Q-RT-PCR primers used for gene expression
experiments.
(DOC)
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